Sneha Khedkar is a freelance science journalist based out of Bengaluru, India. She writes about health and life sciences. Her work has appeared in Scientific American, Knowable Magazine, New Scientist and The Scientist, among other publications. She completed an M.Sc. in biochemistry at the Maharaja Sayajirao University of Baroda, after which she was a research fellow studying stem cells in the skin. Her website is https://www.snehakhedkar.com/.
Sneha Khedkar
Contributing writer
From this contributor
Egyptian fruit bats’ neural patterns represent different experimenters
The findings underscore the importance of accounting for “experimenter effects” on lab animals.
Egyptian fruit bats’ neural patterns represent different experimenters
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.